Global Anti-Thrombin III Testing Market 2022-2026

Description

List of Tables

Technavio has been monitoring the anti-thrombin III testing market and it is poised to grow by $ 161.48 mn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. Our report on the anti-thrombin III testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by existence of tests related to anti-thrombin III, increase in the number of people with hypertension, and shift toward rapid diagnostics.

The anti-thrombin III testing market analysis includes the end-user segment and geographic landscape.

Technavio's anti-thrombin III testing market is segmented as below:

By End-user

Hospitals
Laboratories
Academic and research institutes

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the presence of various blood clotting disorders as one of the prime reasons driving the anti-thrombin III testing market growth during the next few years. Also, rise in the geriatric population and prevalence of inherited anti-thrombin deficiency will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on anti-thrombin III testing market covers the following areas:

Anti-thrombin III testing market sizing
Anti-thrombin III testing market forecast
Anti-thrombin III testing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-thrombin III testing market vendors that include Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biron Health Group Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Invitae Corp., Merck KGaA, Meridian Bioscience Inc., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Scripps Laboratories Inc., Sekisui Diagnostics LLC, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., and Werfenlife SA. Also, the anti-thrombin III testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73611

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

5.1 Market segments
Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
5.2 Comparison by End-user
Exhibit 26: Chart on Comparison by End-user
Exhibit 27: Data Table on Comparison by End-user
5.3 Hospitals - Market size and forecast 2021-2026
Exhibit 28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
5.4 Laboratories - Market size and forecast 2021-2026
Exhibit 32: Chart on Laboratories - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Laboratories - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Laboratories - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Laboratories - Year-over-year growth 2021-2026 (%)
5.5 Academic and research institutes - Market size and forecast 2021-2026
Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by End-user
Exhibit 40: Market opportunity by End-user ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Abbott Laboratories
Exhibit 89: Abbott Laboratories - Overview
Exhibit 90: Abbott Laboratories - Business segments
Exhibit 91: Abbott Laboratories - Key news
Exhibit 92: Abbott Laboratories - Key offerings
Exhibit 93: Abbott Laboratories - Segment focus
10.4 Becton Dickinson and Co.
Exhibit 94: Becton Dickinson and Co. - Overview
Exhibit 95: Becton Dickinson and Co. - Business segments
Exhibit 96: Becton Dickinson and Co. - Key news
Exhibit 97: Becton Dickinson and Co. - Key offerings
Exhibit 98: Becton Dickinson and Co. - Segment focus
10.5 Bio Rad Laboratories Inc.
Exhibit 99: Bio Rad Laboratories Inc. - Overview
Exhibit 100: Bio Rad Laboratories Inc. - Business segments
Exhibit 101: Bio Rad Laboratories Inc. - Key news
Exhibit 102: Bio Rad Laboratories Inc. - Key offerings
Exhibit 103: Bio Rad Laboratories Inc. - Segment focus
10.6 Danaher Corp.
Exhibit 104: Danaher Corp. - Overview
Exhibit 105: Danaher Corp. - Business segments
Exhibit 106: Danaher Corp. - Key news
Exhibit 107: Danaher Corp. - Key offerings
Exhibit 108: Danaher Corp. - Segment focus
10.7 F. Hoffmann La Roche Ltd.
Exhibit 109: F. Hoffmann La Roche Ltd. - Overview
Exhibit 110: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 111: F. Hoffmann La Roche Ltd. - Key news
Exhibit 112: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 113: F. Hoffmann La Roche Ltd. - Segment focus
10.8 Grifols SA
Exhibit 114: Grifols SA - Overview
Exhibit 115: Grifols SA - Business segments
Exhibit 116: Grifols SA - Key offerings
Exhibit 117: Grifols SA - Segment focus
10.9 Siemens AG
Exhibit 118: Siemens AG - Overview
Exhibit 119: Siemens AG - Business segments
Exhibit 120: Siemens AG - Key news
Exhibit 121: Siemens AG - Key offerings
Exhibit 122: Siemens AG - Segment focus
10.10 Sysmex Corp.
Exhibit 123: Sysmex Corp. - Overview
Exhibit 124: Sysmex Corp. - Business segments
Exhibit 125: Sysmex Corp. - Key offerings
Exhibit 126: Sysmex Corp. - Segment focus
10.11 Thermo Fisher Scientific Inc.
Exhibit 127: Thermo Fisher Scientific Inc. - Overview
Exhibit 128: Thermo Fisher Scientific Inc. - Business segments
Exhibit 129: Thermo Fisher Scientific Inc. - Key news
Exhibit 130: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 131: Thermo Fisher Scientific Inc. - Segment focus
10.12 Transasia Bio Medicals Ltd.
Exhibit 132: Transasia Bio Medicals Ltd. - Overview
Exhibit 133: Transasia Bio Medicals Ltd. - Product / Service
Exhibit 134: Transasia Bio Medicals Ltd. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 135: Inclusions checklist
Exhibit 136: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 137: Currency conversion rates for US$
11.4 Research methodology
Exhibit 138: Research methodology
Exhibit 139: Validation techniques employed for market sizing
Exhibit 140: Information sources
11.5 List of abbreviations
Exhibit 141: List of abbreviations
- growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
- product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.